Orion Nutraceuticals Inc. (ORI.CN) Research

Orion Nutraceuticals Inc., a company established in 2017 and headquartered in Vancouver, Canada, concentrates its efforts on developing pharmaceutical treatments for respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) within the Canadian market. The firm previously operated under the name Cline Capital Corp.

Market snapshot

Symbol
ORI.CN
Price
$0.40
Day change
0.00%
Market cap
$11.7M
P/E ratio
-189.63x
52-week range
0.4-0.4
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Peer companies

  • Cloud DX Inc. (CDX.V)
  • Chalice Brands Ltd. (CHAL.CN)
  • CanaFarma Hemp Products Corp. (CNFA.CN)
  • CloudMD Software & Services Inc. (DOC.V)
  • EXMceuticals Inc. (EXM.CN)
  • Khiron Life Sciences Corp. (KHRN.V)
  • Nass Valley Gateway Ltd. (NVG.CN)
  • RIV Capital Inc. (RIV.CN)

Open Orion Nutraceuticals Inc. (ORI.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.